| ￥3285 | |
| L00897-1 | |
|
|
|
|
|
|
|
|
|
| Product Description |
The CytoSinct TCR αβ Nanobeads, human is used for in vitro depletion of TCR αβ+ cells from fresh or frozen peripheral blood mononuclear cells (PBMCs), leukapheresis products, or single-cell suspension based on the surface expression of human TCR αβ. To begin the isolation, Nanobeads are added to the cells. The cells/beads mixed suspension is loaded onto a CytoSinct column placed in the CytoSinct magnet, or other compatible columns with magnets. The TCR αβ+ cells labeled with Nanobeads are retained within the column and unlabeled cells (TCR αβ- cells) are flushed out during the wash step. After removing the column from the magnetic field, the retained TCR αβ+ cells can be eluted as the positively selected cell fraction. |
| Capacity |
|
||||||||||||
| Format | Supplied in phosphate-buffered saline (PBS), containing Human Serum Albumin (HSA) and Poloxamer 188. | ||||||||||||
| Components |
1 mL or 7.5 mL CytoSinct TCR αβ Nanobeads, human Nanobeads conjugated to monoclonal anti-human TCR αβ antibodies. |
||||||||||||
| Storage & Stability | Store at 2-8 °C. Do not freeze. |
»
TCR αβ+ T cells were depleted from human PBMCs. TCR αβ+ cells were stained with anti-TCR αβ (clone: BW242/412) PE and gated on Live/hCD45+. »
For research use only. Not intended for human and animal therapeutic or diagnostic use.
